
DNA Valuation
Ginkgo Bioworks Holdings Inc
- Overview
- Forecast
- Valuation
- Earnings
DNA Relative Valuation
DNA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, DNA is overvalued; if below, it's undervalued.
Historical Valuation
Ginkgo Bioworks Holdings Inc (DNA) is now in the Overvalued zone, suggesting that its current forward PS ratio of 4.46 is considered Overvalued compared with the five-year average of -16.40. The fair price of Ginkgo Bioworks Holdings Inc (DNA) is between 7.51 to 10.96 according to relative valuation methord. Compared to the current price of 14.90 USD , Ginkgo Bioworks Holdings Inc is Overvalued By 35.9%.
Relative Value
Fair Zone
7.51-10.96
Current Price:14.90
35.9%
Overvalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
1.19
P/B
Median3y
1.73
Median5y
3.40
-44.19
FCF Yield
Median3y
-34.36
Median5y
-25.92
Competitors Valuation Multiple
The average P/S ratio for DNA's competitors is 2.62, providing a benchmark for relative valuation. Ginkgo Bioworks Holdings Inc Corp (DNA) exhibits a P/S ratio of 4.46, which is 70.31% above the industry average. Given its robust revenue growth of 27.34%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

GAME
GameSquare Holdings Inc
1.270
USD
0.00%

PYPL
PayPal Holdings Inc
77.820
USD
+1.51%

PPC
Pilgrims Pride Corp
47.290
USD
-1.62%

GM
General Motors Co
52.340
USD
-1.49%

ROKU
Roku Inc
90.050
USD
-0.22%

F
Ford Motor Co
11.260
USD
-1.05%

EXP
Eagle Materials Inc
220.040
USD
-0.65%

DELL
Dell Technologies Inc
128.350
USD
+0.89%

BNGO
Bionano Genomics Inc
3.460
USD
-1.14%

CVS
CVS Health Corp
58.750
USD
-5.01%
FAQ

Is Ginkgo Bioworks Holdings Inc (DNA) currently overvalued or undervalued?
Ginkgo Bioworks Holdings Inc (DNA) is now in the Overvalued zone, suggesting that its current forward PS ratio of 4.46 is considered Overvalued compared with the five-year average of -16.40. The fair price of Ginkgo Bioworks Holdings Inc (DNA) is between 7.51 to 10.96 according to relative valuation methord. Compared to the current price of 14.90 USD , Ginkgo Bioworks Holdings Inc is Overvalued By 35.90% .

What is Ginkgo Bioworks Holdings Inc (DNA) fair value?

How does DNA's valuation metrics compare to the industry average?

What is the current P/B ratio for Ginkgo Bioworks Holdings Inc (DNA) as of Jul 25 2025?

What is the current FCF Yield for Ginkgo Bioworks Holdings Inc (DNA) as of Jul 25 2025?

What is the current Forward P/E ratio for Ginkgo Bioworks Holdings Inc (DNA) as of Jul 25 2025?
